TuHURA Biosciences Inc (NAS:HURA)
$ 2.59 +0.065 (+2.57%) Market Cap: 164.94 Mil Enterprise Value: 159.37 Mil PE Ratio: 0 PB Ratio: 7.19 GF Score: 12/100

TuHURA Biosciences Inc Corporate Update Call Transcript

Dec 11, 2025 / 01:30PM GMT
Release Date Price: $1.04 (+0.49%)
Operator

Good morning and welcome to TuHURA Biosciences' corporate update call. With us today are Dr. James Bianco, CEO of TuHURA; Dan Dearborn, CFO of TuHURA; and Monique Kosse, IR for TuHURA. (Operator Instructions)

As a reminder, ladies and gentlemen, this conference call is being recorded, and your participation implies consent to our recording of this call. If you do not agree with these terms, please disconnect at this time.

Thank you. I would now like to turn the call over to Monique Kosse, Investor Relations for TuHURA Biosciences. Monique?

Monique Kosse
TuHURA Biosciences Inc - Investor Relations

Thank you, Leo, and welcome, everyone. Before we begin, I would like to remind everyone that statements made during this call related to TuHURA's expected future performance, future business prospects, future events or plans are forward-looking statements as defined under the Private Securities Litigation Reform Act of 1995.

Although the company believes that the expectations reflected in such forward-looking statements are based upon

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot